Atea Pharmaceuticals shares owned by GSA Capital Partners
Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by GSA Capital Partners
from 13F filings
Historical chart of GSA Capital Partners investment in Atea Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Atea Pharmaceuticals held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Atea Pharmaceuticals by GSA Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $457k | 150k | 3.05 |
| 2023-09-30 | $835k | 278k | 3.00 |
| 2023-06-30 | $733k | 196k | 3.74 |
| 2023-03-31 | $480k | 143k | 3.35 |
| 2022-12-31 | $274k | 57k | 4.81 |
| 2022-06-30 | $178k | 25k | 7.10 |